Biocomputing 2010 2009
DOI: 10.1142/9789814295291_0035
|View full text |Cite
|
Sign up to set email alerts
|

Enabling Personal Genomics With an Explicit Test of Epistasis

Abstract: One goal of personal genomics is to use information about genomic variation to predict who is at risk for various common diseases. Technological advances in genotyping have spawned several personal genetic testing services that market genotyping services directly to the consumer. An important goal of consumer genetic testing is to provide health information along with the genotyping results. This has the potential to integrate detailed personal genetic and genomic information into healthcare decision making. D… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
36
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
7
1

Relationship

5
3

Authors

Journals

citations
Cited by 41 publications
(36 citation statements)
references
References 32 publications
0
36
0
Order By: Relevance
“…Using the filtered data containing all 1,439 participants, we considered the best 1-, 2-, and 3-locus models. Permutation testing (1,000-fold) was done using MDRpt (version 1.0) to obtain a P value from an explicit test of interaction (Greene et al 2010), which evaluates the significance of each interaction independent of any main effects. Finally, the ''high risk'' versus ''low risk'' groups identified from each MDR model were analyzed using a logistic regression model that also contained age, sex, follow-up time, and advanced adenoma at baseline, which are strong predictors of metachronous neoplasia, to determine if the genetic combinations added additional information.…”
Section: Discussionmentioning
confidence: 99%
“…Using the filtered data containing all 1,439 participants, we considered the best 1-, 2-, and 3-locus models. Permutation testing (1,000-fold) was done using MDRpt (version 1.0) to obtain a P value from an explicit test of interaction (Greene et al 2010), which evaluates the significance of each interaction independent of any main effects. Finally, the ''high risk'' versus ''low risk'' groups identified from each MDR model were analyzed using a logistic regression model that also contained age, sex, follow-up time, and advanced adenoma at baseline, which are strong predictors of metachronous neoplasia, to determine if the genetic combinations added additional information.…”
Section: Discussionmentioning
confidence: 99%
“…Availability of the methods as part of the open-source MDR software package will make this possible. Second, it will be interesting to compare the covariate adjustment methods to the new explicit test of epistasis that holds marginal effects constant during permutation testing for MDR [Greene et al, 2010]. Can covariate adjustment methods be used in conjunction with these special permutation test methods?…”
Section: Discussionmentioning
confidence: 99%
“…multifactordimensionalityreduction.org) (Greene et al 2010; Moore and Andrews 2015; Ritchie et al 2001). The comparative analysis was aimed at conforming to the originally reported form of the interaction as closely as possible, using a logistic regression framework.…”
Section: Analytical Approachesmentioning
confidence: 99%
“…MDR analyses were performed individually for each interaction (considering no fewer and no more SNPs than the set of SNPs particular to a given interaction), using the collapsed dataset and adjusting for sub-study. The significance of each analysis was evaluated using both explicit (Greene et al 2010) and non-explicit permutation tests, with 10,000 permutations each. The nonexplicit permutation tests were not used to declare the significance of any interaction; instead, they were performed to assess the possible presence of non-interacting effects, and to allow comparability with interactions originally analyzed in that manner.…”
Section: Analytical Approachesmentioning
confidence: 99%
See 1 more Smart Citation